---
title: "NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib"
ocid: "ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2021-03-11"
---

# NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166.json)

## Summary

NHS England has completed a public procurement process for the contract titled "NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib", which falls under the pharmaceutical products industry category. The procurement was conducted using an accelerated open procedure and had a total contract value of £17,300,000. The contract period commenced on 15 January 2021 and concluded on 31 October 2021. The procurement process officially ended on 8 December 2020, with the award notice published on 11 March 2021, concerning various delivery addresses across the United Kingdom and beyond.

This tender presents significant opportunities for growth to businesses supplying pharmaceutical products, particularly for small and medium-sized enterprises (SMEs) given their eligibility to participate. Companies with expertise in pharmaceuticals, especially those dealing with products like Fulvestrant, Darunavir, and Imatinib, will find this procurement well-suited for them. The involvement of multiple large suppliers indicates a competitive market environment, thus enhancing the prospects for SMEs to engage as valuable partners in future contracts.

## Notice

NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/55758111-02de-455e-9d99-0de2dd7cd0d3 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Accelerated Open procedure (above threshold) |
| Tender suitability | SME |
| Awardee scale | Large, SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 Mar 2021 |
| Submission deadline | 8 Dec 2020 |
| Future notice date | Not specified |
| Award date | 4 Jan 2021 |
| Contract period | 15 Jan 2021 - 31 Oct 2021 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £17,300,000 |
| Lots value | Not specified |
| Awards value | £17,300,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD71 East Merseyside |
| Local authority | Halton |
| Electoral ward | Halton Lea |
| Westminster constituency | Runcorn and Helsby |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 10 |
| Supplier names | ACCORD-UK; ASTRAZENECA; CIPLA (EU; DR.REDDY'S LABORATORIES (UK; JANSSEN-CILAG; NOVARTIS PHARMACEUTICALS; SANDOZ; TEVA; THORNTON AND ROSS; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 11 Mar 2021 at 12:18 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/55758111-02de-455e-9d99-0de2dd7cd0d3

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/55758111-02de-455e-9d99-0de2dd7cd0d3
  11th March 2021 - Awarded contract notice on Contracts Finder
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHoL/abR42U.6ZWzTWmCLCQCAVpJMCxPdsdZb0EB6grQN2fY
  Document No. 03 - Framework Agreement and Terms and Conditions
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHoQ/8ItxBwERUc4ZTYc62Vfh6pv9PUnNdGUpcnQ_3QrUT6Q
  Parties Appointed to the Framework - NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHoG/kQ7bi90Yz4hOXQRPEy8BXDvMmP80ZApxIZiC_dLdw1k
  Transparency Award Schedule - NHS National Pharmaceuticals - Fulvestrant and Darunavir
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kHoB/pGcFf0NqqOM0F56RGEIoJRXgmhOP.DJ2.VD_EkbJoMs
  Transparency Award Schedule - NHS National Pharmaceuticals - Imatinib

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166.json.